ERK1/2 inhibition overcomes resistance to venetoclax in AML by altering mitochondrial metabolism

被引：0
|
作者：
Sharma, Priyanka
Ostermann, Lauren
Piya, Sujan
Baran, Natalia
Tyagi, Anudishi
Hindley, Christopher
Dao, Kim-Hien
Sims, Martin
Battula, V. Lokesh
Andreeff, Michael
Borthakur, Gautam
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-3860
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3860
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Inhibition of ERK1/2 Phosphorylation: A New Strategy to Stimulate Elastogenesis in the Aorta
    Lannoy, Morgane
    Slove, Severin
    Louedec, Liliane
    Choqueux, Christine
    Journe, Clement
    Michel, Jean-Baptiste
    Jacob, Marie-Paule
    HYPERTENSION, 2014, 64 (02) : 423 - +
  • [32] Inhibition of VEGFR2 overcomes venetoclax-resistance in diffuse large B-cell lymphoma cells
    Shi, Yuanfei
    Xu, Yi
    Xie, Wanzhuo
    GENES & DISEASES, 2023, 10 (04) : 1147 - 1149
  • [33] ME-344, a novel isoflavone mitochondrial inhibitor, in combination with venetoclax constitutes a new metabolism-targeted approach to overcome resistance to Bcl-2 inhibition and standard of care treatment in AML
    Hurrish, Katie H.
    Su, Yongwei
    Patel, Shraddha
    Wiley, Sandra E.
    Hou, Zhanjun
    Carter, Jenna
    Kalpage, Hasini
    Huttemann, Maik
    Weng, Connie
    Edwards, Holly
    Polin, Lisa
    Li, Jing
    Yang, Jay
    Matherly, Larry H.
    Konoplev, Sergej Naumovich
    Taub, Jeffrey W.
    Konopleva, Marina
    Ge, Yubin
    Baran, Natalia
    CANCER RESEARCH, 2022, 82 (12)
  • [34] Constitutive activation of ERK1/2 signaling protects against myocardial ischemia via inhibition of mitochondrial fragmentation in the aging heart
    Zhao, Qiang
    Liu, Fen
    Zhao, Qian
    Zhang, Jinyu
    Luo, Junyi
    Li, Xiaomei
    Yang, Yining
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (06)
  • [35] Cephalochromin-Induced Mitochondrial Damage Overcomes Venetoclax-Resistance in Acute Myeloid Leukemia Models
    Do Nascimento, Mariane Cristina
    Pereira-Martins, Diego A.
    Alcantara, Guilherme Augusto Sousa
    Lima, Keli
    Vicari, Hugo Passos
    Pena Ferreira, Marcelo Jose
    Costa-Lotufo, Leticia Veras
    Huls, Gerwin A.
    Schuringa, Jan Jacob
    Machado-Neto, Joao Agostinho
    Rego, Eduardo Magalhaes
    BLOOD, 2023, 142
  • [36] ERK1/2 in immune signalling
    Lucas, Richard M.
    Luo, Lin
    Stow, Jennifer L.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2022, : 1341 - 1352
  • [37] Mxi2 sustains ERK1/2 phosphorylation in the nucleus by preventing ERK1/2 binding to phosphatases
    Casar, Berta
    Rodriguez, Javier
    Gibor, Gilad
    Seger, Rony
    Crespo, Piero
    BIOCHEMICAL JOURNAL, 2012, 441 : 571 - 578
  • [38] ERK5 Signalling and Resistance to ERK1/2 Pathway Therapeutics: The Path Less Travelled?
    Cook, Simon J.
    Lochhead, Pamela A.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [39] ERK1/2 activity contributes to gemcitabine resistance in pancreatic cancer cells
    Zheng, Chunning
    Jiao, Xuelong
    Jiang, Yingsheng
    Sun, Shaochuan
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2013, 41 (02) : 300 - 306
  • [40] Control of cell death and mitochondrial fission by ERK1/2 MAP kinase signalling
    Cook, Simon J.
    Stuart, Kate
    Gilley, Rebecca
    Sale, Matthew J.
    FEBS JOURNAL, 2017, 284 (24) : 4177 - 4195
12345